Michael L. Mallory

1.7k total citations
24 papers, 412 citations indexed

About

Michael L. Mallory is a scholar working on Infectious Diseases, Animal Science and Zoology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael L. Mallory has authored 24 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 12 papers in Animal Science and Zoology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael L. Mallory's work include Viral gastroenteritis research and epidemiology (21 papers), Animal Virus Infections Studies (12 papers) and Viral Infections and Immunology Research (10 papers). Michael L. Mallory is often cited by papers focused on Viral gastroenteritis research and epidemiology (21 papers), Animal Virus Infections Studies (12 papers) and Viral Infections and Immunology Research (10 papers). Michael L. Mallory collaborates with scholars based in United States, Nicaragua and United Kingdom. Michael L. Mallory's co-authors include Ralph S. Baric, Lisa C. Lindesmith, Paul D. Brewer-Jensen, Rachel L. Graham, Kari Debbink, Jan Vinjé, Verónica Costantini, Eric Donaldson, George Georgiou and Jacob Kocher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and Journal of Virology.

In The Last Decade

Michael L. Mallory

23 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Mallory United States 12 372 178 163 106 53 24 412
Paul D. Brewer-Jensen United States 11 286 0.8× 145 0.8× 133 0.8× 94 0.9× 43 0.8× 22 367
Jennifer H. Lun Australia 9 263 0.7× 91 0.5× 82 0.5× 66 0.6× 28 0.5× 14 297
Mukti Kant Nayak India 17 516 1.4× 265 1.5× 236 1.4× 99 0.9× 98 1.8× 22 633
Laura Cristal Magaña United States 8 341 0.9× 133 0.7× 180 1.1× 59 0.6× 49 0.9× 13 407
Joseph A. Kendra United States 8 218 0.6× 82 0.5× 85 0.5× 57 0.5× 25 0.5× 16 256
Christina J. Castro United States 9 365 1.0× 127 0.7× 195 1.2× 66 0.6× 52 1.0× 21 446
Yuqi Huo China 11 252 0.7× 98 0.6× 86 0.5× 120 1.1× 16 0.3× 40 292
Keiji Mise Japan 10 331 0.9× 125 0.7× 181 1.1× 30 0.3× 51 1.0× 15 395
Tin-Nok Hung Hong Kong 6 257 0.7× 99 0.6× 101 0.6× 67 0.6× 47 0.9× 9 292

Countries citing papers authored by Michael L. Mallory

Since Specialization
Citations

This map shows the geographic impact of Michael L. Mallory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Mallory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Mallory more than expected).

Fields of papers citing papers by Michael L. Mallory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Mallory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Mallory. The network helps show where Michael L. Mallory may publish in the future.

Co-authorship network of co-authors of Michael L. Mallory

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Mallory. A scholar is included among the top collaborators of Michael L. Mallory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Mallory. Michael L. Mallory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barclay, Leslie, Anna Montmayeur, Jennifer L. Cannon, et al.. (2025). Molecular Evolution and Epidemiology of Norovirus GII.4 Viruses in the United States. The Journal of Infectious Diseases. 232(4). 933–942. 3 indexed citations
2.
Atochina‐Vasserman, Elena N., Lisa C. Lindesmith, Carmen Mirabelli, et al.. (2024). Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection. npj Vaccines. 9(1). 182–182. 4 indexed citations
3.
Mallory, Michael L., Jennifer E. Munt, Tara M. Narowski, et al.. (2024). COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort. Science Advances. 10(24). eadi1379–eadi1379.
4.
Powers, John M., Sarah R. Leist, Michael L. Mallory, et al.. (2024). Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection. Virus Research. 341. 199319–199319. 1 indexed citations
5.
Bucardo, Filemón, Michael L. Mallory, Fredman González, et al.. (2024). Charting the Impact of Maternal Antibodies and Repeat Exposures on Sapovirus Immunity in Early Childhood From a Nicaraguan Birth Cohort. The Journal of Infectious Diseases. 231(2). 480–489. 2 indexed citations
6.
Brewer-Jensen, Paul D., Sylvia Becker‐Dreps, Fredman González, et al.. (2023). Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters. Frontiers in Immunology. 14. 1229724–1229724. 2 indexed citations
7.
Lindesmith, Lisa C., Paul D. Brewer-Jensen, Kathleen O’Reilly, et al.. (2023). Emergent variant modeling of the serological repertoire to norovirus in young children. Cell Reports Medicine. 4(3). 100954–100954. 6 indexed citations
8.
Lindesmith, Lisa C., Paul D. Brewer-Jensen, Michael L. Mallory, et al.. (2022). Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure. Viruses. 14(6). 1293–1293. 4 indexed citations
9.
Shi, Yunlong, Ari Zeida, Caitlin E. Edwards, et al.. (2022). Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein. Proceedings of the National Academy of Sciences. 119(6). 30 indexed citations
10.
Brewer-Jensen, Paul D., Yaoska Reyes, Sylvia Becker‐Dreps, et al.. (2022). Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity. Viruses. 14(9). 2053–2053. 5 indexed citations
11.
Becker‐Dreps, Sylvia, Paul D. Brewer-Jensen, Fredman González, et al.. (2022). Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children. Journal of the Pediatric Infectious Diseases Society. 11(10). 459–462. 5 indexed citations
12.
Tse, Longping V., Rita M. Meganck, Lily E. Adams, et al.. (2022). Generation of Mature DENVs via Genetic Modification and Directed Evolution. mBio. 13(3). e0038622–e0038622. 12 indexed citations
13.
Ruis, Christopher, Lisa C. Lindesmith, Michael L. Mallory, et al.. (2020). Preadaptation of pandemic GII.4 noroviruses in unsampled virus reservoirs years before emergence. Virus Evolution. 6(2). veaa067–veaa067. 19 indexed citations
14.
Lindesmith, Lisa C., Paul D. Brewer-Jensen, Michael L. Mallory, et al.. (2020). Virus–Host Interactions Between Nonsecretors and Human Norovirus. Cellular and Molecular Gastroenterology and Hepatology. 10(2). 245–267. 25 indexed citations
15.
Verardi, Raffaello, Lisa C. Lindesmith, Yaroslav Tsybovsky, et al.. (2020). Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes. npj Vaccines. 5(1). 110–110. 10 indexed citations
16.
Lindesmith, Lisa C., Jonathan R. McDaniel, Anita Changela, et al.. (2019). Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination. Immunity. 50(6). 1530–1541.e8. 78 indexed citations
17.
Lindesmith, Lisa C., Michael L. Mallory, Kari Debbink, et al.. (2018). Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion. mSphere. 3(1). 40 indexed citations
18.
Lindesmith, Lisa C., Michael L. Mallory, Taylor Jones, et al.. (2017). Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination. The Journal of Infectious Diseases. 215(6). 984–991. 18 indexed citations
19.
Lindesmith, Lisa C., Jacob Kocher, Eric Donaldson, et al.. (2017). Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes. The Journal of Infectious Diseases. 216(10). 1227–1234. 32 indexed citations
20.
Lindesmith, Lisa C., Paul D. Brewer-Jensen, Michael L. Mallory, et al.. (2017). Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape. The Journal of Infectious Diseases. 217(7). 1145–1152. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026